Integrating Centralised and Site Monitoring in a Risk-Based Approach for Study Oversight

About this session

This talk will explore how centralised monitoring and site monitoring can be effectively combined in a risk-based manner to enhance study oversight at a major pharmaceutical company. We will showcase how, at MSD, we plan to achieve the following by having integrated centralised monitoring in a risk-based approach: better patient safety and data quality, more efficient resource allocation, and faster issue detection and resolution.

Speakers

• GC

  Greg Cinciala

  Senior Director, Clinical Quality Operations Lead, Clinical Trials · MSD

  Speaker

• HW

  Helen Wong

  Senior Director, RBQM Strategy and Implementation Lead · MSD

  Speaker